Efficacy and safety of valsartan in children aged 1-5 years with hypertension, with or without chronic kidney disease: a randomized, double-blind study followed by open-label phase

CONCLUSION: Valsartan was efficacious and well tolerated in children 1 to 5 years of age with hypertension, with or without CKD.The study has been registered at ClinicalTrials.gov (Identifier: NCT01617681).PMID:34543161 | DOI:10.1080/03007995.2021.1982681

Source: Current Medical Research and Opinion - September 20, 2021 Category: Research Authors: Augustina Jankauskiene Dorota Drozdz Anna Wasilewska Rejane de Paula-Bernardes Robert Glazer Michele Valentin Monique Tan YannTong Chiang Kiran Bapatla Source Type: research